Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders
Editat de Nicola Brunetti-Pierrien Limba Engleză Hardback – 31 mai 2017
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1068.67 lei 6-8 săpt. | |
Springer International Publishing – 7 mai 2018 | 1068.67 lei 6-8 săpt. | |
Hardback (1) | 1075.45 lei 6-8 săpt. | |
Springer International Publishing – 31 mai 2017 | 1075.45 lei 6-8 săpt. |
Preț: 1075.45 lei
Preț vechi: 1132.06 lei
-5% Nou
Puncte Express: 1613
Preț estimativ în valută:
205.89€ • 214.01$ • 170.70£
205.89€ • 214.01$ • 170.70£
Carte tipărită la comandă
Livrare economică 06-20 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319534558
ISBN-10: 3319534556
Pagini: 286
Ilustrații: IX, 220 p. 32 illus., 19 illus. in color.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.5 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3319534556
Pagini: 286
Ilustrații: IX, 220 p. 32 illus., 19 illus. in color.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.5 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Overview: gene transfer strategies, principles, applications.- Manufacturing viral gene therapy vectors: general approaches and challenges.- Retrovirus- and lentivirus-based vectors.- Preclinical and clinical applications of retroviral vectors.- Preclinical and clinical applications of lentiviral vectors.- Retrovirus and lentivirus integration.- Adenovirus-based vectors for gene therapy.- Adenoviral vector-host interactions.- Helper-dependent adenoviral vectors.- Gene therapy for cancer treatment.- Oncolytic adenoviruses for cancer treatment.- Vaccination by gene transfer vectors.- AAV vectors: general features and applications.- Adaptive immune response to viral vector delivery.- Herpes viruses: general features and applications.- RNA interference-based strategy for treatment of human diseases.- Antisense oligonucleotide based therapeutics.- Gene editing strategies.- Nonviral vectors.
Notă biografică
Nicola Brunetti-Pierri graduated in Medicine from Federico II University of Naples, Italy. After his residency in Pediatrics at Federico II University of Naples, he moved to Baylor College of Medicine, Houston, USA for a post-doctoral research fellowship and clinical trainings in medical genetics and biochemical genetics. He is currently an Associate Professor of Pediatrics at Federico II University, Naples, Italy and an Associate Investigator at the Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy. As a pediatrician and geneticist, he studies genetic diseases and inborn errors of metabolism and his research focuses at developing novel therapies for these disorders.
Textul de pe ultima copertă
In this book, leading international experts analyze state-of-the-art advances in gene transfer vectors for applications in inherited disorders and also examine the toxicity profiles of these methods. The authors discuss the strengths and weaknesses of available vectors in the clinical setting, and specifically focus on the challenges and possible solutions that researchers are testing in order to improve the safety of gene therapy for genetic diseases. This comprehensive and authoritative overview of vector development is a necessary text for researchers, toxicologists, pharmacologists, molecular biologists, physicians, and students in these fields.
Caracteristici
A comprehensive review of different vector platforms by international experts in the field
Highlights advances on gene transfer vectors, their disease applications, and their toxicity profiles
Provides detailed discussions of vector type, the biomedical knowledge of the disease targets, and the complexities and toxicology of gene delivery
Includes supplementary material: sn.pub/extras
Highlights advances on gene transfer vectors, their disease applications, and their toxicity profiles
Provides detailed discussions of vector type, the biomedical knowledge of the disease targets, and the complexities and toxicology of gene delivery
Includes supplementary material: sn.pub/extras